Who
In numbers
- Trades disclosed
- 10
- Buys
- 0
- Sells
- 3
- Bought
- $0
- Sold
- $40K
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 15 Sep 2020
- Last trade
- 27 Jan 2026
- Last filed
- 29 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 27 Jan 2026filed 29 Jan 2026 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 27 Jan 2026filed 29 Jan 2026 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Code A | —15,000 at $0.00 | filing |
| 17 Nov 2025filed 19 Nov 2025 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Sold | $7,3163,266 at $2.24 | filing |
| 7 Aug 2024filed 9 Aug 2024 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Code A | —19,607 at $0.00 | filing |
| 17 Nov 2023filed 17 Nov 2023 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Code A | —19,607 at $0.00 | filing |
| 15 Nov 2023filed 17 Nov 2023 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Sold | $32K19,607 at $1.62 | filing |
| 10 Nov 2022filed 14 Nov 2022 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Code A | —19,607 at $0.00 | filing |
| 19 Nov 2021filed 8 Jul 2022 | VIVS VivoSim LabsBiotechnology | SEC FORM 4 Sold | $767145 at $5.29 | filing |
| 7 Oct 2021filed 12 Oct 2021 | VIVS VivoSim Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —17,500 at $0.00 | filing |
| 15 Sep 2020filed 17 Sep 2020 | VIVS VivoSim Labsoption or derivative · Biotechnology | SEC FORM 4 Code A | —35,000 at $0.00 | filing |
News
Charles River Laboratories International (NYSE:CRL) versus VivoSim Labs (NASDAQ:VIVS) Head-To-Head ContrastVIVS · dailypolitical.com · 22 Oct 2026VivoSim Labs Extends NAMkind Platform with Human Disease Models for Efficacy Testing and Mechanistic Biomarker ProfilingVIVS · manilatimes.net · 21 Oct 2026
0 headlines in the last 90 days name David Gobel; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.